Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

Crinetics Pharmaceuticals, Inc. - Common Stock (NQ:CRNX)

37.44 -0.78 (-2.04%)
Streaming Delayed Price Updated: 2:51 PM EDT, Mar 10, 2026 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

All News about Crinetics Pharmaceuticals, Inc. - Common Stock

< Previous 1 2 3 4 5 6 7 8 9 Next >
News headline image
58 Biggest Movers From Friday ↗
Gainers CAI International, Inc. (NYSE: CAI) shares surged 46.9% to close at $56.05 on Friday after the company agreed to a $1.1 billion takeover by Mitsubishi HC Capital Inc.... 
Via Benzinga
Benzinga's Top Ratings Upgrades, Downgrades For June 18, 2021 ↗
Upgrades According to JP Morgan, the prior rating for Orion Engineered Carbons SA (NYSE: 
Via Benzinga
News headline image
32 Stocks Moving In Friday's Mid-Day Session ↗
Gainers CAI International, Inc. (NYSE: CAI) shares jumped 46.4% to $55.86 after the company agreed to a $1.1 billion takeover by Mitsubishi HC Capital Inc. Sykes Enterprises,... 
Via Benzinga
News headline image
The Past Week's Notable Insider Buys Included Biotechs, Public Offerings, A SPAC And More ↗
Insider buying can be an encouraging signal for potential investors, especially when markets are near all-time highs. Once again, some insiders were taking advantage of recent... 
Via Benzinga
News headline image
Insider Buys Crinetics Pharmaceuticals Shares ↗
A Form 4 filing filed with the SEC on Friday, April 9 showed that Perceptive Advisors Llc bought 304,136 shares of Crinetics Pharmaceuticals Inc (NASDAQ:CRNX) at an average... 
Via Benzinga
Topics Regulatory Compliance
News headline image
12 Health Care Stocks Moving In Thursday's Intraday Session ↗
Gainers 180 Life Sciences (NASDAQ:ATNF) stock increased by 21.18% to $9.61 during Thursday's regular session. Trading volume for this security as of 12:32 EST is 9.2... 
Via Benzinga
News headline image
The Daily Biotech Pulse: Immutep Extends Run, FDA Nod For Gilead, Merck, Bristol-Myers Squibb Release Late-Stage Cancer Immunotherapy Data ↗
Here's a roundup of top developments in the biotech space over the last 24 hours: Scaling The Peaks (Biotech Stocks Hitting 52-week Highs April 7) Aclaris Therapeutics, Inc... 
Via Benzinga
< Previous 1 2 3 4 5 6 7 8 9 Next >
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.